China regulator promises action to fix ‘grim’ drug safety situation – FiercePharma Manufacturing
0
China’s drug regulator has confirmed what the FDA has known for some time. Oversight of pharmaceutical manufacturing in the country that is the major supplier of cheap active pharmaceutical ingredients (APIs) is “weak.” But the China Food and Drug Administration, as it has other times, promised that it will get better in the new year.
Read more – FiercePharma Manufacturing